News|Articles|June 2, 2004
- Pharmaceutical Technology-06-02-2004
- Volume 28
- Issue 6
Will CROs Take On the Risks of Strategic Outsourcing?
Author(s)Jim Miller
It's not clear whether contract service providers can deliver the performance improvements and costs savings that drug companies expect from large, long-term, semi-exclusive contracts.
Advertisement
Articles in this issue
over 21 years ago
Microbial Testing in Support of Aseptic Processingover 21 years ago
June 2004over 21 years ago
Uniformity of Bioprocessing Equipment Manufacturingover 21 years ago
Research Tips To Find Packaging Facts Fastover 21 years ago
New Technologies Optimize Biotech Process Efficiencyover 21 years ago
Battles Escalate Over Prescription Drug Importsover 21 years ago
USP's Semi-Hemiquinquennial Meetingover 21 years ago
In the Spotlight - June 2004Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
2
Why Context Matters in Validating Biomarker Assays for Bioanalysis
3
Targeted high resolution metabolite screening workflows
4
Application of alternative electron-based fragmentation for identification of drug metabolites and quantification of complex peptide therapeutics
5
